Termination of Early Pregnancy — Menstrual Induction

  • M. Bygdeman
Conference paper

Zusammenfassung

Suction curettage, the most prevalent technique for first trimester abortion, was developed to minimize complications of infection and blood loss encountered with dilatation and sharp curettage. Suction curettage, however, is not without immediate and future risks, including the hazards of anesthesia and the potential for cervical damage resulting from mechanical dilatation of the cervix. A desire to minimize these risks led to the development of the early suction abortion which has been variously termed menstrual regulation, menstrual extraction, and mini-abortion (Karman and Potts 1972). Later experience with this technique, however, demonstrated the routine need for local anesthesia to minimize vasovagal symptoms and in some patients mechanical cervical dilatation could not be avoided.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baulieu EE (1985) An antiprogestin steroid with contragestive activity in women. In: Baulieu EE, Segal SJ (eds) The Antiprogestin steroid RU 486 and human fertility control. Plenum, New York, pp 1–6Google Scholar
  2. Bygdeman M, Swahn ML (1985) Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. Contraception 32:45–51PubMedCrossRefGoogle Scholar
  3. Bygdeman M, Borell U, Leader A, Lundström V, Martin JN Jr, Eneroth P, Gréen K (1976) Induction of first and second trimester abortion by the vaginal administration of 15-methyl-PGF2 methyl ester. In: Samuelsson B, Paoletti R (eds) Advances in prostaglandin and thromboxane research, vol 2. Raven, New York, pp 693–704Google Scholar
  4. Bygdeman M, Christensen NJ, Gréen K, Zheng S, Lundström V (1983) Termination of early pregnancy — future development. Acta Obstet Gynecol Scand [suppl] 113:125–129CrossRefGoogle Scholar
  5. Bygdeman M, Christensen NJ, Gréen K, Vesterqvist O (1984) Self-administration at home of prostaglandin for termination of early pregnancy. In: Toppozada M, Bygdeman M, Hafez ESE (eds) Prostaglandins and fertility regulation. MTP Press, Lancaster, pp 83–90CrossRefGoogle Scholar
  6. Hamberger L, Nilsson B, Björn Rasmussen E, Atterfelt P, Wiqvist N (1978) Early abortion by vaginal prostaglandin suppositories. Contraception 17:183–194PubMedCrossRefGoogle Scholar
  7. Herrmann W, Wyss R, Riondel A, Philibert D, Teutsch G, Sekiz E, Baulieu EE (1982) Effet d’un steroid antiprogesterone chez la femme: interruption du cycle menstruel et de la grossesse au debut. CR Acad Sci [III] 294:933–938Google Scholar
  8. Karim SMM, Rao B, Ratnam SS, Prasad RNW, Wong YM, Ilancheran A (1977) Termination of early pregnancy (menstrual induction) with 16-phenoxy-ω-tetranor PGE2 methyl sulfonyla-mide. Contraception 16:377–381PubMedCrossRefGoogle Scholar
  9. Karman H, Potts M (1972) Very early abortion using syringe as a vacuum source. Lancet i:1051–1052CrossRefGoogle Scholar
  10. Kovacs L, Sas M, Resch BA, Ugocsai G, Swahn ML, Bygdeman M, Rowe PJ (1984) Termination of very early pregnancy by RU 486, an antiprogestational compound. Contraception 29:399–410PubMedCrossRefGoogle Scholar
  11. Lauersen NH (1986) Induced abortion. In: Bygdeman M, Berger GS, Keith LG (eds) Prostaglandins and their inhibitors in clinical obstetrics and gynecology. MTP Press, Lancaster, pp 271–314Google Scholar
  12. Lundström V, Bygdeman M, Fotiou S, Gréen K, Kinoshita K (1977) Abortion in early pregnancy by vaginal administration of 16,16-dimethyl-PGE2 in comparison with vacuum aspiration. Contraception 16:167–173CrossRefGoogle Scholar
  13. Ragab MJ, Edelman D (1976) Early termination of pregnancy. A comparative study of intrauterine PGF; and vacuum aspiration. Prostaglandins 11:275–283CrossRefGoogle Scholar
  14. Rosén AS, Nysted I, Bygdeman M, Lundström V (1979) Acceptability of a non-surgical method to terminate very early pregnancy in comparison to vacuum aspiration. Contraception 19:107–117PubMedCrossRefGoogle Scholar
  15. Rosén AS, von Knorring K, Bygdeman M, Christensen N (1984) Randomized comparison of prostaglandin treatment in hospital or at home with vacuum aspiration for termination of early pregnancy. Contraception 29:423–435PubMedCrossRefGoogle Scholar
  16. Swahn ML, Bygdeman M(1987) Interruption of early gestation with prostaglandins and antiprogestin. In: Diczfalusy E, Bygdeman M (eds) Fertility regulation today and tomorrow. Raven, New York (in press) Serono Symposia 36:109–118Google Scholar
  17. Swahn ML, Cekan S, Wang G, Lundström V, Bygdeman M (1985) Pharmacokinetic and clinical studies of RU 486 for fertility regulation. In: Baulieu EE, Segal SJ (eds) The antiprogestin steroid RU 486 and human fertility control. Plenum, New York, pp 249–258Google Scholar
  18. Takagi S, Tomida Y, Itoh K, Matsukawa R, Sakata H, Yoshida T, Iwasa Y, Ninagawa T, Hiroshima T (1977) Termination of early pregnancy by ONO-802 (16,16-dimethyl-trans-Δ2-PGE1 methyl ester). Prostaglandins 14:791–798PubMedCrossRefGoogle Scholar
  19. WHO Prostaglandin Task Force (1982) Termination of very early first trimester pregnancy by vaginal administration of 16,16-dimethyl-trans-Δ2-PGE1 methyl ester. Asia Oceania J Obstet Gynecol 8:263–268Google Scholar
  20. WHO Task Force on Post-Ovulatory Methods for Fertility Control (1987) Menstrual regulation by intramuscular injections of 16-phenocy-tetranor PGE2 methyl sulfonylamide. Br J Obstet Gynaecol (in press)Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1988

Authors and Affiliations

  • M. Bygdeman
    • 1
  1. 1.Department of Obstetrics and GynecologyStockholmGermany

Personalised recommendations